Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Single Arm Study of Enzalutamide in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer Previously Treated With Abiraterone Acetate

NCT02116582 is registered in ClinicalTrials.gov with Astellas Pharma Europe B.V. as lead sponsor.

NCT NCT02116582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02116582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Single Arm Study of Enzalutamide in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer Previously Treated With Abiraterone Acetate
Lead sponsor
Astellas Pharma Europe B.V.
Phase
Phase 4
Overall status
Completed
Start date
May 23, 2014
Completion date
September 29, 2017
Enrollment
215 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic castration-resistant prostate cancer